Last reviewed · How we verify
Lucron Depot
At a glance
| Generic name | Lucron Depot |
|---|---|
| Also known as | leuprolide acetate for depot suspension |
| Sponsor | Repros Therapeutics Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lucron Depot CI brief — competitive landscape report
- Lucron Depot updates RSS · CI watch RSS
- Repros Therapeutics Inc. portfolio CI